Modified Adsorbed Diphtheria And Tetanus Toxoids And Pertussis Vaccine
Item Name Code (INC) 48259
Additional Information for Modified Adsorbed Diphtheria And Tetanus Toxoids And Pertussis Vaccine
Modified Adsorbed Diphtheria And Tetanus Toxoids And Pertussis Vaccine, also known as DTaP vaccine, is a combination vaccine used to protect against three infectious diseases: diphtheria, tetanus, and pertussis (whooping cough). It is classified under the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies.
Diphtheria is a bacterial infection that can cause severe respiratory problems and damage to the heart and nervous system. Tetanus, also known as lockjaw, is caused by a bacterial toxin and can lead to muscle stiffness and spasms. Pertussis is a highly contagious respiratory infection characterized by severe coughing fits.
The DTaP vaccine contains inactivated toxins from the diphtheria and tetanus bacteria, as well as components of the pertussis bacteria. These components stimulate the immune system to produce protective antibodies against these diseases.
The vaccine is typically administered in a series of doses during infancy and childhood, with booster shots recommended in adolescence and adulthood. It is an essential part of routine immunization schedules worldwide, as it helps prevent the spread of these potentially serious diseases.
It is important to consult with a healthcare professional for specific information about the administration, dosage, and potential side effects of the DTaP vaccine.